GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lucy Scientific Discovery Inc (NAS:LSDI) » Definitions » Days Sales Outstanding

Lucy Scientific Discovery (Lucy Scientific Discovery) Days Sales Outstanding : 9.13 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Lucy Scientific Discovery Days Sales Outstanding?

Lucy Scientific Discovery's average Accounts Receivable for the three months ended in Dec. 2023 was $0.00 Mil. Lucy Scientific Discovery's Revenue for the three months ended in Dec. 2023 was $0.01 Mil. Hence, Lucy Scientific Discovery's Days Sales Outstanding for the three months ended in Dec. 2023 was 9.13.

The historical rank and industry rank for Lucy Scientific Discovery's Days Sales Outstanding or its related term are showing as below:

LSDI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 85.88   Med: 365   Max: 365
Current: 85.88

During the past 3 years, Lucy Scientific Discovery's highest Days Sales Outstanding was 365.00. The lowest was 85.88. And the median was 365.00.

LSDI's Days Sales Outstanding is ranked worse than
64.76% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.7 vs LSDI: 85.88

Lucy Scientific Discovery's Days Sales Outstanding increased from Dec. 2022 (0.00) to Dec. 2023 (9.13).


Lucy Scientific Discovery Days Sales Outstanding Historical Data

The historical data trend for Lucy Scientific Discovery's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lucy Scientific Discovery Days Sales Outstanding Chart

Lucy Scientific Discovery Annual Data
Trend Jun21 Jun22 Jun23
Days Sales Outstanding
- - 365.00

Lucy Scientific Discovery Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - 91.25 - 9.13

Competitive Comparison of Lucy Scientific Discovery's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Lucy Scientific Discovery's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lucy Scientific Discovery's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lucy Scientific Discovery's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Lucy Scientific Discovery's Days Sales Outstanding falls into.



Lucy Scientific Discovery Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Lucy Scientific Discovery's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

Days Sales Outstanding (A: Jun. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )*Days in Period
=( (0 + 0.007) / 1 ) / 0.007*365
=0.007 / 0.007*365
=365.00

Lucy Scientific Discovery's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0 + 0.001) / 1 ) / 0.01*365 / 4
=0.001 / 0.01*365 / 4
=9.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lucy Scientific Discovery  (NAS:LSDI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Lucy Scientific Discovery Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Lucy Scientific Discovery's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Lucy Scientific Discovery (Lucy Scientific Discovery) Business Description

Traded in Other Exchanges
N/A
Address
301-1321 Blanshard Street, Victoria, BC, CAN, V8W 0B6
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.
Executives
Richard D Nanula director, officer: Executive Chairman C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Charles B Nemeroff director C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Paul Abramowitz director C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Brian Zasitko officer: Chief Financial Officer C/O LUCY SCIENTIFIC DISCOVERY, INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Scott M. Reeves director C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Christopher Mcelvany director, officer: President and CEO C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Livio Susin director C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Brittany Kaiser director C/O LUCY SCIENTIFIC DISCOVERY INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6
Assad J Kazeminy officer: Chief Scientific Officer C/O LUCY SCIENTIFIC, INC., 301-1321 BLANSHARD STREET, VICTORIA A1 V8W 0B6